Cargando…

Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification

PURPOSE: The aim of this study was to observe the mechanism of Fructus Lycii (FL), Rehmanniae Radix Praeparata (RRP) and Paeonia lactiflora (PL) in treating age-related macular degeneration (AMD) based on network pharmacology and biological experiments. METHODS: Bioactive compounds, potential target...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Zuo, Jing, Hu, Tianming, Shi, Xiaoqing, Zhu, Yujie, Wu, Hao, Xia, Ying, Shi, Wei, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254409/
https://www.ncbi.nlm.nih.gov/pubmed/34234414
http://dx.doi.org/10.2147/DDDT.S310481
_version_ 1783717724047802368
author Chen, Xi
Zuo, Jing
Hu, Tianming
Shi, Xiaoqing
Zhu, Yujie
Wu, Hao
Xia, Ying
Shi, Wei
Wei, Wei
author_facet Chen, Xi
Zuo, Jing
Hu, Tianming
Shi, Xiaoqing
Zhu, Yujie
Wu, Hao
Xia, Ying
Shi, Wei
Wei, Wei
author_sort Chen, Xi
collection PubMed
description PURPOSE: The aim of this study was to observe the mechanism of Fructus Lycii (FL), Rehmanniae Radix Praeparata (RRP) and Paeonia lactiflora (PL) in treating age-related macular degeneration (AMD) based on network pharmacology and biological experiments. METHODS: Bioactive compounds, potential targets of FL, RRP and PL, and genes related to AMD, were acquired from public databases. Functional and pathway enrichment analyses of the core targets were conducted by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, the finding was further verified with cell experiments. The MTT assay and flow cytometric analysis were used to assess cell viability and apoptosis. The production of reactive oxygen species (ROS) was analyzed by DCFH-DA staining; the activity of antioxidant enzymes was chemically measured with assay kits. The expression of key proteins was evaluated by Western blot analysis. RESULTS: Fifty-nine active compounds, 182 potential targets, and 2536 AMD-related human genes were identified. A total of 103 key targets of the three herbs on AMD were identified by protein–protein interaction (PPI) analysis. The abovementioned targets were correlated with nuclear receptor activity, oxidative stress, and apoptosis pathways according to the GO and KEGG analyses. MTT assay and flow cytometry demonstrated that pretreatment of ARPE-19 cells with the three herbs significantly increased cell viability and decreased apoptosis induced by H(2)O(2). The three herbs might reduce the intracellular ROS levels and increase the SOD and CAT activities after H(2)O(2). Furthermore, the three herbs significantly inhibited oxidative stress via increasing the expression of Nrf2, HO-1 and NQO1. CONCLUSION: The combined results of network pharmacology and validation experiments showed that FL, RRP and PL reduce oxidative stress and apoptosis in RPE cells to exert its effect in the treatment of AMD.
format Online
Article
Text
id pubmed-8254409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82544092021-07-06 Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification Chen, Xi Zuo, Jing Hu, Tianming Shi, Xiaoqing Zhu, Yujie Wu, Hao Xia, Ying Shi, Wei Wei, Wei Drug Des Devel Ther Original Research PURPOSE: The aim of this study was to observe the mechanism of Fructus Lycii (FL), Rehmanniae Radix Praeparata (RRP) and Paeonia lactiflora (PL) in treating age-related macular degeneration (AMD) based on network pharmacology and biological experiments. METHODS: Bioactive compounds, potential targets of FL, RRP and PL, and genes related to AMD, were acquired from public databases. Functional and pathway enrichment analyses of the core targets were conducted by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, the finding was further verified with cell experiments. The MTT assay and flow cytometric analysis were used to assess cell viability and apoptosis. The production of reactive oxygen species (ROS) was analyzed by DCFH-DA staining; the activity of antioxidant enzymes was chemically measured with assay kits. The expression of key proteins was evaluated by Western blot analysis. RESULTS: Fifty-nine active compounds, 182 potential targets, and 2536 AMD-related human genes were identified. A total of 103 key targets of the three herbs on AMD were identified by protein–protein interaction (PPI) analysis. The abovementioned targets were correlated with nuclear receptor activity, oxidative stress, and apoptosis pathways according to the GO and KEGG analyses. MTT assay and flow cytometry demonstrated that pretreatment of ARPE-19 cells with the three herbs significantly increased cell viability and decreased apoptosis induced by H(2)O(2). The three herbs might reduce the intracellular ROS levels and increase the SOD and CAT activities after H(2)O(2). Furthermore, the three herbs significantly inhibited oxidative stress via increasing the expression of Nrf2, HO-1 and NQO1. CONCLUSION: The combined results of network pharmacology and validation experiments showed that FL, RRP and PL reduce oxidative stress and apoptosis in RPE cells to exert its effect in the treatment of AMD. Dove 2021-06-28 /pmc/articles/PMC8254409/ /pubmed/34234414 http://dx.doi.org/10.2147/DDDT.S310481 Text en © 2021 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Xi
Zuo, Jing
Hu, Tianming
Shi, Xiaoqing
Zhu, Yujie
Wu, Hao
Xia, Ying
Shi, Wei
Wei, Wei
Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title_full Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title_fullStr Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title_full_unstemmed Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title_short Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification
title_sort exploration of the effect and mechanism of fructus lycii, rehmanniae radix praeparata, and paeonia lactiflora in the treatment of amd based on network pharmacology and in vitro experimental verification
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254409/
https://www.ncbi.nlm.nih.gov/pubmed/34234414
http://dx.doi.org/10.2147/DDDT.S310481
work_keys_str_mv AT chenxi explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT zuojing explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT hutianming explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT shixiaoqing explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT zhuyujie explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT wuhao explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT xiaying explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT shiwei explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification
AT weiwei explorationoftheeffectandmechanismoffructuslyciirehmanniaeradixpraeparataandpaeonialactiflorainthetreatmentofamdbasedonnetworkpharmacologyandinvitroexperimentalverification